InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The regulatory hammer is hitting VERU stock investors hard today as the FDA denies a crucial authorization for Veru's Covid-19 drug.
The post Why Is VERU Stock Down 50% Today? appeared first on InvestorPlace.
More From InvestorPlace